Literature DB >> 20300720

[Infantile hemangioma. Successful treatment with propranolol].

J Baetz1, S Eigelshoven, J Marquard, D Bruch-Gerharz, B Homey, T Meissner.   

Abstract

We report on an infant, aged four months, suffering from a severe hemangioma of the left labium majus. We induced systemic treatment with propranolol in off-label-use over a period of 5 1/2 months. A few weeks after onset of the treatment, the size and color of hemangioma was obviously reduced; finally there was an almost complete regression. This result underlines the role of propranolol in treatment of problematic hemangioma.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20300720     DOI： 10.1007/s00105-010-1938-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  6 in total

1.  Beta blockade induces apoptosis in cultured capillary endothelial cells.

Authors:  Sally K Sommers Smith; Dennis M Smith
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

2.  Hemangiomas in infancy and childhood. S 2k Guideline of the German Society of Dermatology with the working group Pediatric Dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine.

Authors:  Rainer Grantzow; Peter Schmittenbecher; Hansjörg Cremer; Peter Höger; Jochen Rössler; Henning Hamm; Ulrich Hohenleutner
Journal:  J Dtsch Dermatol Ges       Date:  2008-02-25       Impact factor: 5.584

3.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

4.  Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

Authors:  Lisa M Buckmiller; Patrick D Munson; Umesh Dyamenahalli; Yuemeng Dai; Gresham T Richter
Journal:  Laryngoscope       Date:  2010-04       Impact factor: 3.325

5.  Propranolol treatment for hemangioma of infancy: risks and recommendations.

Authors:  Leslie P Lawley; Elaine Siegfried; Jane L Todd
Journal:  Pediatr Dermatol       Date:  2009 Sep-Oct       Impact factor: 1.588

6.  [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].

Authors:  H Löffler; C Kosel; H Cremer; W Kachel
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751
  6 in total
  3 in total

1.  [Successful treatment of orbital capillary hemangioma with propranolol].

Authors:  C Mai; A Vega-Pérez; M Koch; E Bertelmann
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

2.  Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.

Authors:  Kari Martin; Francine Blei; Francine Bleib; Sarah L Chamlin; Yvonne E Chiu; Ilona J Frieden; Peter C Frommelt; Maria C Garzon; Eun-Kyung M Kwon; Susan MacLellan-Tobert; Anthony J Mancini; Marcia Seefeldt; Robert Sidbury; Dawn H Siegel; Beth A Drolet; Robert J Boucek
Journal:  Pediatr Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.588

Review 3.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.